IDEAS home Printed from https://ideas.repec.org/a/spr/aphecp/v13y2015i3p273-279.html
   My bibliography  Save this article

How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States?

Author

Listed:
  • Don Husereau
  • Anthony Culyer
  • Peter Neumann
  • Philip Jacobs

Abstract

Canadian and US health systems have often been characterized as having vastly different approaches to the financing and delivery of healthcare, with Canada portrayed as more reliant on rationing based on costs. In this article, we examine the similarities and differences between the two countries, the evolution and current role of health economic evaluation, and the roles played by health economists. We suggest both countries have similarly used economic evaluation to a limited extent for drug and immunization decisions, with variability in use more of a reflection of the incompleteness of both systems and their inherent institutional barriers rather than political ideology. Copyright Springer International Publishing Switzerland 2015

Suggested Citation

  • Don Husereau & Anthony Culyer & Peter Neumann & Philip Jacobs, 2015. "How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States?," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 273-279, June.
    • Handle: RePEc:spr:aphecp:v:13:y:2015:i:3:p:273-279
    DOI: 10.1007/s40258-014-0133-6
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s40258-014-0133-6
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s40258-014-0133-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. C. David Naylor, 1992. "The Canadian health care system: A model for America to emulate?," Health Economics, John Wiley & Sons, Ltd., vol. 1(1), pages 19-37, April.
    2. Peter J. Neumann, 2009. "American Exceptionalism and American Health Care: Implications for the US Debate on Cost-Effectiveness Analysis," Briefing 000232, Office of Health Economics.
    3. Evans, R.G. & Barer, M. & Morgan, S., 2000. "Health Economists Meet the Fourth Tempter: Drog Dependency and Scientific Discourse," Centre for Health Services and Policy Research 2000:16r, University of British Columbia - Centre for Health Services and Policy Research..
    4. Culyer, A J, 1989. "The Normative Economics of Health Care Finance and Provision," Oxford Review of Economic Policy, Oxford University Press and Oxford Review of Economic Policy Limited, vol. 5(1), pages 34-58, Spring.
    5. Guyatt, Gordon & Drummond, Michael & Feeny, David & Tugwell, Peter & Stoddart, Greg & Haynes, R. Brian & Bennett, Kathryn & Labelle, Roberta, 1986. "Guidelines for the clinical and economic evaluation of health care technologies," Social Science & Medicine, Elsevier, vol. 22(4), pages 393-408, January.
    6. Karen Gerard & Gavin Mooney, 1993. "Qaly league tables: Handle with care," Health Economics, John Wiley & Sons, Ltd., vol. 2(1), pages 59-64, April.
    7. Steve Morgan & Morris Barer & Robert Evans, 2000. "Health economists meet the fourth tempter: drug dependency and scientific discourse," Health Economics, John Wiley & Sons, Ltd., vol. 9(8), pages 659-667, December.
    8. Williams, Iestyn & Bryan, Stirling, 2007. "Understanding the limited impact of economic evaluation in health care resource allocation: A conceptual framework," Health Policy, Elsevier, vol. 80(1), pages 135-143, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. McDaid, David & Park, A-La & Wahlbeck, Kristian, 2019. "The economic case for the prevention of mental illness," LSE Research Online Documents on Economics 100054, London School of Economics and Political Science, LSE Library.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Vuorenkoski, Lauri & Toiviainen, Hanna & Hemminki, Elina, 2003. "Drug reimbursement in Finland--a case of explicit prioritising in special categories," Health Policy, Elsevier, vol. 66(2), pages 169-177, November.
    2. McMahon, Meghan & Morgan, Steve & Mitton, Craig, 2006. "The Common Drug Review: A NICE start for Canada?," Health Policy, Elsevier, vol. 77(3), pages 339-351, August.
    3. Maynard, Alan & McDaid, David, 2003. "Evaluating health interventions: exploiting the potential," Health Policy, Elsevier, vol. 63(2), pages 215-226, February.
    4. Paul Grootendorst, 2009. "Patents, Public-Private Partnerships or Prizes – How should we support pharmaceutical innovation?," Social and Economic Dimensions of an Aging Population Research Papers 250, McMaster University.
    5. Baltussen, Rob & Ament, Andre & Leidl, Reiner, 1996. "Making cost assessments based on RCTs more useful to decision-makers," Health Policy, Elsevier, vol. 37(3), pages 163-183, September.
    6. Pieter H. M. van Baal & Talitha L. Feenstra & Rudolf T. Hoogenveen & G. Ardine de Wit & Werner B. F. Brouwer, 2007. "Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a ‘perfect’ cost–utility ratio," Health Economics, John Wiley & Sons, Ltd., vol. 16(4), pages 421-433, April.
    7. Tony J Culyer & Alan Wagstaff, 1991. "Need, equality and social justice," Working Papers 090chedp, Centre for Health Economics, University of York.
    8. Banta, David, 2003. "The development of health technology assessment," Health Policy, Elsevier, vol. 63(2), pages 121-132, February.
    9. Kanavos, Panos & Visintin, Erica & Gentilini, Arianna, 2023. "Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries," Social Science & Medicine, Elsevier, vol. 331(C).
    10. Paul Anand & Laurence S. J. Roope & Anthony J. Culyer & Ron Smith, 2020. "Disability and multidimensional quality of life: A capability approach to health status assessment," Health Economics, John Wiley & Sons, Ltd., vol. 29(7), pages 748-765, July.
    11. Culyer, Anthony J. & Evans, Robert G., 1996. "Mark Pauly on welfare economics: Normative rabbits from positive hats," Journal of Health Economics, Elsevier, vol. 15(2), pages 243-251, April.
    12. Böhm, Katharina & Schmid, Achim & Götze, Ralf & Landwehr, Claudia & Rothgang, Heinz, 2013. "Five types of OECD healthcare systems: Empirical results of a deductive classification," Health Policy, Elsevier, vol. 113(3), pages 258-269.
    13. Joanna Coast & Richard Smith & Paula Lorgelly, 2008. "Should the capability approach be applied in Health Economics?," Health Economics, John Wiley & Sons, Ltd., vol. 17(6), pages 667-670, June.
    14. Morik, Katharina & Imhoff, Michael & Brockhausen, Peter & Joachims, Thorsten & Gather, Ursula, 2000. "Knowledge discovery and knowledge validation in intensive care," Technical Reports 2000,14, Technische Universität Dortmund, Sonderforschungsbereich 475: Komplexitätsreduktion in multivariaten Datenstrukturen.
    15. W. Dominika Wranik & Liesl Gambold & Natasha Hanson & Adrian Levy, 2017. "The evolution of the cancer formulary review in Canada: Can centralization improve the use of economic evaluation?," International Journal of Health Planning and Management, Wiley Blackwell, vol. 32(2), pages 232-260, April.
    16. Philippe Batifoulier & John Latsis & Jacques Merchiers, 2010. "Les priorités de la prise en charge financière des soins. Une approche par la philosophie du besoin," EconomiX Working Papers 2010-2, University of Paris Nanterre, EconomiX.
    17. Adam Oliver, 2005. "The English National Health Service: 1979‐2005," Health Economics, John Wiley & Sons, Ltd., vol. 14(S1), pages 75-99, September.
    18. Stolpe, Michael, 2003. "Ressourcen und Ergebnisse der globalen Gesundheitsökonomie: Einführung und Überblick," Kiel Working Papers 1177, Kiel Institute for the World Economy (IfW Kiel).
    19. Kevin Haninger & James K. Hammitt, 2011. "Diminishing Willingness to Pay per Quality‐Adjusted Life Year: Valuing Acute Foodborne Illness," Risk Analysis, John Wiley & Sons, vol. 31(9), pages 1363-1380, September.
    20. Brouwer, W. B. F. & Koopmanschap, M. A. & Rutten, F. F. H., 1999. "Productivity losses without absence: measurement validation and empirical evidence," Health Policy, Elsevier, vol. 48(1), pages 13-27, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:13:y:2015:i:3:p:273-279. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.